UPENDS
UPENDS, an e-cigarette brand that prioritizes users’ experience and aims to become the favorite brand for vapers, has recently released its brand new next-gen mesh coil technology and UpBAR GT, the world’s first car concept disposable vape equipped with the next-gen mesh coil.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20221227005002/en/
(Photo: Business Wire)
What Does the Next-gen Mesh Coil Mean to the Vape Market?
With the surge of the disposable vape market, countless manufacturers and brands influx into this track, pushing technology innovation quickly. Mesh coil, the key tech of disposable vapes, becomes the essential of tech innovation, which profoundly influences performance like flavor reproduction and puffs. It is obvious that products with stronger next-gen mesh coils will be more competitive in the market.
Next-gen Mesh Coil Comes with Significant Improvements in Performance.
Since the release of its “Mesh Coil is the Future” brand proposition, UPENDS has been dedicated to the innovation of mesh coil technology and has made many breakthroughs. After lab tests and adjustments, UPENDS next-gen mesh coil has been invented successfully. “Compared with traditional mesh coils, its flavor reproduction increased by 38%, puffs increased by 33% and energy efficiency increased by 36% with the same e-liquid capacity”, said Doctor WU, the Chief Product Officer of UPENDS. “We are so excited to release the next-gen mesh coil, and we believe that our customers will be satisfied with the strong performance and longevity it brings.”
UPENDS Makes A Comprehensive Breakthrough in Mesh Coil Technology.
Not only optimizing the coil, UPENDS has also upgraded technologies of the whole cotton coil platform for better performance and quality control. It features a V-shaped air inlet design that can accelerate aerosol delivery, decrease condensate and provide stronger smoke, compared with normal straight channels. Meanwhile, there’s literally no possibility of burnt tastes and oil leakage thanks to its industry-first Tesla value, unique separate air exchange and e-liquid supply channels and multi-layer seal leakage-proof. In addition, it adopts fully-automated manufacturing process technology, aiming to guarantee both production efficiency and stable high quality.
UpBAR GT with Next-gen Mesh Coil is Coming in January 2023.
So what does the next-gen mesh coil bring to UPENDS? UpBAR GT, the first disposable vape equipped with this technology will be the answer. As the “World’s First Car Concept Disposable Vape”, UpBAR GT seeks inspiration from sports cars and stands out from the crowd with its streamlined design and V-shaped grille decorations. GT is the abbreviation of Grand Touring, a type of car designed for high speed and long-distance driving, which also implies the features such as high quality, stability, security and more of UpBAR GT. In addition, there is an eco-friendly version using recycled materials.
About UPENDS
Founded in 2019, UPENDS is an e-cigarette brand dedicated to the field of Electronic Nicotine Delivery Systems. The good reputation of UPENDS as a leading e-cigarette brand in Europe attributes to its excellent manufacturing technology and quality, simple design, and cost-effective features. Currently, UPENDS is expanding its global development. UPENDS persistent pursuit is to prioritize users’ experience and to be Vaper's favorite. For more information, please visit www.upends.com.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20221227005002/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Shield and PwC UK Forge Strategic Collaboration to Deliver Future-Ready Communications Compliance18.9.2025 08:00:00 CEST | Press release
Collaboration brings together Shield's AI-first platform with PwC's surveillance expertise to deliver measurable compliance outcomes Shield, a leading AI platform for digital communication governance and archiving, today announced a collaboration with PwC UK, one of the world’s most trusted professional services firms. The alliance brings together Shield’s unified, cloud-native solution with PwC’s specialist expertise in communications surveillance delivery, regulatory compliance and complex programme execution. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250917394739/en/ Shield and PwC launch a strategic collaboration to modernize eComms surveillance with AI-driven compliance solutions for financial institutions. The collaboration is designed to support institutions as they modernise their approach to communications monitoring, helping them implement an advanced and proactive risk management approach at scale and with co
Almirall Presents Long‑Term Results from First Real‑World Dermatology Study Using WHO‑5 Well‑Being Index as Primary Endpoint in the treatment of Psoriasis at EADV 202518.9.2025 08:00:00 CEST | Press release
Results of the POSITIVE study assessing the treatment with tildrakizumab showed sustained improvements in skin clearance, psychological well-being, and improved partner quality of life in adults with moderate-to-severe psoriasis over two years.POSITIVE is the first real-world evidence (RWE) study in dermatology to use the WHO-5 Well-Being Index as a primary endpoint, complementing traditional measures of skin disease (PASI, PGA), quality of life (DLQI), with the assessment of psychological well-being, marking a paradigm shift towards holistic management of psoriasis.The POSITIVE study highlights Almirall’s leadership in advancing patient-centred dermatology aligned with the WHO’s health definition and recent resolution on skin diseases.Almirall’s extensive scientific contributions to EADV 2025 include 44 abstracts across key dermatological conditions including atopic dermatitis, psoriasis, actinic keratosis, and hidradenitis suppurativa, and two expert-led symposia. Almirall, S.A. (ALM
Curatis: FDA Minutes Confirm Positive Outcome of Meeting on 9. September 2025 – Corticorelin on Track for Phase 318.9.2025 07:00:00 CEST | Press release
Curatis Holding AG (SIX:CURN) received the official minutes from the FDA meeting which took place on 9. September. Based on the totality of the feedback and discussions, Curatis can proceed as planned with the clinical development of corticorelin. Corticorelin is under development as a novel treatment intended to reduce or even eliminate steroid use and associated toxicities thereby potentially impacting the quality of life of patients suffering from peritumoral brain edema (PTBE) associated with metastatic (secondary) brain tumors. The virtual meeting with the FDA provided the opportunity to discuss the clinical development plan for corticorelin and encompassed CMC (Chemistry, Manufacturing and Control), nonclinical and clinical aspects. The offical FDA minutes which Curatis received after publication of the half year results reflect the positive outcome. Curatis may proceed without delay to a regulatory submission supporting a pivotal study in patients suffering from PTBE secondary t
Galderma Launches Transformative Skincare Segment With Cetaphil’s New Skin Activator Hydrating & Firming Line, in Partnership With Actor and Filmmaker Mariska Hargitay18.9.2025 07:00:00 CEST | Press release
Cetaphil's new Skin Activator Hydrating & Firming Line harnesses a proprietary formula, co-created with dermatologists and offering targeted, high-performance skincare designed to improve the appearance of skin affected by dermatoporosis The line’s new Skin Activator technology uses microdosed alpha hydroxy acid (AHA) and encapsulated centella asiatica (CICA) to wake up sleeping surface skin cells To help bring this segment-defining product line to life, Cetaphil is partnering with acclaimed actress, director, and advocate, Mariska Hargitay, a powerful voice in embracing beauty at every stage Galderma today announced Cetaphil, the dermatologist-recommended brand trusted by millions with sensitive skin, is redefining daily skincare with its new Skin Activator Hydrating & Firming line. The launch marks an entirely new skincare segment of advanced hydration and firming solutions designed specifically for improving the appearance of aging, thinning, and fragile skin. As people age, surface
Merck Opens Climate-Neutral €150 Million Filter Manufacturing Facility in Ireland18.9.2025 07:00:00 CEST | Press release
Part of company’s €440 million investment in Ireland, strengthens Merck’s in-region-for-region supply resilienceMerck’s first climate-neutral manufacturing facility, powered by 100 percent renewable electricityNew Blarney site in Cork, Ireland expands filter manufacturing capacity, creating more than 200 jobs by 2028 Merck, a leading science and technology company, has opened today its €150 million filter manufacturing facility in Blarney Business Park, Cork, Ireland. The site is Merck’s first manufacturing facility designed for full climate-neutral operations, marking a key milestone in the company’s ambition to achieve climate neutrality by 2040. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250917767425/en/ Merck's new Blarney site in Cork expands company's filter capacity, creating 200+ jobs by 2028 The 3,000-square-meter cleanroom facility supports global demand for critical filtration products used in the manufacturin
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom